Safety of a peanut oral immunotherapy protocol in children with peanut allergy. - Wikidata - wikimedia - TriplyDB

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

http://www.wikidata.org/entity/Q37316978

about

Allergen-specific oral immunotherapy for peanut allergy Oral immunotherapy for peanut allergy Sublingual vs oral immunotherapy for food allergy: identifying the right approach Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy A practical view of immunotherapy for food allergy Future therapies for food allergy Immunotherapy in food allergy.Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy.Food allergy diagnosis and therapy: where are we now?Oral desensitization for food hypersensitivity.Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.Peanut allergy and anaphylaxis Diagnosis and management of food allergies: new and emerging options: a systematic review.A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.Recognition and management of food-induced anaphylaxis.Ara h 1-reactive T cells in individuals with peanut allergy A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab.The safety and efficacy of sublingual and oral immunotherapy for milk allergy.Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy Model Immunotherapeutic approaches for the treatment of eosinophilic esophagitis The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial.Diagnosis, management, and investigational therapies for food allergies.A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic Nuts 'n' guts: transport of food allergens across the intestinal epithelium Advances in immunotherapy for food allergy.New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy.Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.Emerging therapies for food allergy.Pediatric food allergy and mucosal tolerance.An update on immunotherapy for food allergy.Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.Will we be able to desensitize food allergies by either injection or oral immunotherapy?Immunologic similarities between selected autoimmune diseases and peanut allergy: possible new therapeutic approaches.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.The future of food allergy therapeutics.Recent advances in the diagnosis and therapy of peanut allergy.

P2860

Q24200573-25037B98-A657-4408-9F69-0F89A6C7F46A Q24234537-CDFD42F0-8055-4257-9024-86CCEA9B6587 Q24601352-08A037F6-C723-4D40-816C-DD72A313533C Q24617482-7FDA65BD-2C2C-4E23-88C2-750395CAF812 Q26767047-48E7BA65-FCB7-421B-A809-888CD421CBAA Q26828926-7E2AAA67-17B9-43B3-8505-C4ABF9B1B6D9 Q33899364-0641C0DA-3018-4B5A-93CB-AB184C847AB1 Q33906386-77328E7E-FFCF-4A38-BE09-D1DB694921B6 Q34000536-9F761C75-AEB2-46A9-901A-DB4D807E2972 Q34181235-79403B51-2111-413B-A62F-4D0227AB369F Q34398080-AC114831-8C2E-48DA-91C0-C795874844A9 Q34421203-7E3452D4-3A5F-48AA-9862-9A914973F956 Q34446206-8D66E42D-9B95-41FF-9E6C-0312E1BBE4FB Q34698506-A544B7D4-E1A0-4E42-8B2D-FD36B1519B70 Q34986991-D37381DD-C126-4ED5-88F2-67CD5FF20A55 Q35089048-3697E357-8045-4776-A892-DEF56419D617 Q35510416-23193B46-5121-40A2-9B60-62CEABD9D3B6 Q35603477-9782E6CE-EF1A-4D17-9BB1-D815153BA2CA Q35604468-650FEF28-66CE-42F5-AF5C-BCCFC83481E4 Q35894673-ED1F97FD-0F76-47C1-AD5D-293A1777496A Q36220764-651F6054-6B35-4CBD-95FF-8B381EA36D82 Q36256005-02F3D38B-B885-408B-A45E-537A905746CD Q36420821-3BFDB422-6071-49FF-A637-5846A5541FF1 Q36421592-0535212C-2BD3-4E0C-88A9-7AD4B4C418F0 Q36692411-E78D8278-BB80-485D-BA18-C8B5EF089CE5 Q36874668-9208F3A0-3873-4914-8755-400CB6F8529D Q37005082-BF8A7FDA-A358-4583-9462-7021876ABF86 Q37305131-49156B76-9BAD-425F-8C12-BE1F2781E2F8 Q37319886-FF77AD61-057D-41CA-8867-652DB021BF7D Q37523496-E032ED18-CA94-43D1-813E-97BFE0B127DD Q37607069-7B12A03E-9E0A-4061-A0EC-FB9F040F2E13 Q37726651-9EF39203-152D-438F-9FC4-B0020D8BD666 Q37761046-BA843438-E454-4AA3-9949-7F673E83FE94 Q37790586-93FF7756-1643-4BAD-8E26-0A98809CA562 Q37820336-B688FCCD-D96C-4480-A30F-ABE3C8BD427B Q37859642-46C68D1F-A7A9-478F-BF4C-F4D4940FE31C Q37873808-0F554F43-928E-4917-BEE2-A4348835B72D Q37981739-9CFC3AFA-D82D-42E4-AE4C-3ABFADB30698 Q38021923-87E9E0B2-E829-4256-B52B-1D0EE42C6D14 Q38111422-AC69CDCC-A694-4B29-A3B4-9DD2F2620E6F

P2860

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

http://www.wikidata.org/entity/Q37316978

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@en

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@nl

type

label

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@en

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@nl

prefLabel

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@en

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@nl

P1433

Q37316978-850DA126-F245-4E49-92C1-19EB1690BF54

P1476

Q37316978-F6A537EE-9A9A-47BB-B800-BE724206038E

P2093

Q37316978-441465B8-B09B-4F46-AF63-9E82B49A8542

Q37316978-50344567-B587-4840-A865-5CFDAF989A70

Q37316978-53E36C43-11BB-4DC0-8261-30798D592D33

Q37316978-560008C0-820E-4E56-AD52-748BF275F0E3

Q37316978-AB6D80B0-AFEE-41FA-A023-ED182D4E72F9

Q37316978-B6A4402A-98BF-46D1-9946-910046228699

Q37316978-F7CA2532-05CE-428C-B59C-FEE054560932

P2860

Q37316978-315CC792-0C3F-45CF-904F-A267AC2B0410

Q37316978-4A31608B-AA6A-470B-BB9F-8D51E3F02659

Q37316978-4F12A6C1-5365-4A72-AF58-DA965CEDAEC6

Q37316978-59D9270B-8FF0-4930-9291-2FBEB3387106

Q37316978-75540B09-05AB-4FA1-94C4-C671075015B8

Q37316978-7B88DE28-20F9-4759-B455-8FE88F231DF4

Q37316978-8566754A-5F20-4A0B-A2AF-B608B84CFF17

Q37316978-AA03CCE2-60C6-4890-BCFF-00706D4ADF3C

Q37316978-ADFE6997-20AC-4AC7-9BA3-CAFDF839AFE5

Q37316978-BA685BCD-7E97-4F3E-B683-877F50106EA5

P304

Q37316978-CC71DA4E-DFBC-4B9B-A922-C9B987B11774

P31

Q37316978-5A757A02-A72A-44BF-80C1-898E3F0B1D5B

P356

Q37316978-027B5D15-4BEC-4A2F-9FC2-1BE7B9D9F626

P407

Q37316978-E35B78AA-6F62-4E62-921D-A4EDC03F6BDA

P433

Q37316978-E7076F8C-425D-491F-9982-99BB634AC540

P478

Q37316978-039DC496-713F-4640-92EB-14F8357F9970

P50

Q37316978-B47F8D14-4D39-4514-89AF-8C2000A58D03

P577

Q37316978-0C5D657F-68D2-4C3A-B48F-3C8B39E2A5FD

P5875

Q37316978-743760FC-53A2-48D2-8067-CD6E051A78D9

P698

Q37316978-71291F59-AA30-4DFA-978C-440BB2DC9DF1

P921

Q37316978-03DA1725-B1DB-4831-8CC0-F214A05A2F5A

P932

Q37316978-E8AF2F98-6A0C-4448-BAC5-80A557634A1C

P356

J.JACI.2009.03.045

P1433

The Journal of Allergy and Clinical Immunology

P1476

Safety of a peanut oral immunotherapy protocol in children with peanut allergy.

@en

P2093

A Wesley Burks

http://www.w3.org/2001/XMLSchema#string

Alison M Hofmann

http://www.w3.org/2001/XMLSchema#string

Amy M Scurlock

http://www.w3.org/2001/XMLSchema#string

Janet Kamilaris

http://www.w3.org/2001/XMLSchema#string

Kricia P Palmer

http://www.w3.org/2001/XMLSchema#string

Pamela H Steele

http://www.w3.org/2001/XMLSchema#string

Stacie M Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of anti-IgE therapy in patients with peanut allergy

Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract

Fatal and near-fatal anaphylactic reactions to food in children and adolescents.

Specific oral tolerance induction in food allergy.

The natural history of peanut and tree nut allergy.

Peanut allergy: emerging concepts and approaches for an apparent epidemic.

Allergenic characteristics of a modified peanut allergen.

Egg allergy: are all childhood food allergies the same?

Peanut allergy: recurrence and its management.

P304

286-91, 291.e1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2009.03.045

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Yuliya Lokhnygina

P577

2009-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26248708

http://www.w3.org/2001/XMLSchema#string

P698

19477496

http://www.w3.org/2001/XMLSchema#string

P921

P932

2731305

http://www.w3.org/2001/XMLSchema#string